CB Insights
Technology Market Intelligence
Technology Market Intelligence
Life Sciences Partners is a venture capital firm specializing in early- to mid-stage life sciences companies.
Phone: 31 20 664 5500
Johannes Vermeerplein 9
Amsterdam, 1071 DV
Netherlands
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2019-09-10 | Pharvaris | Series B | $66M | Bain Capital Ventures, Foresite Capital, IDInvest Partners, Kurma Partners, venBIO, and Venrock |
| 2019-09-06 | Xeltis | Series D | $11.59M | Kurma Partners, VI Partners, and Ysios Capital Partners |
| 2019-09-05 | iSTAR Medical | Series C | $44.22M | BNP Paribas Fortis, Capricorn Partners, Demeter Partners, Earlybird Venture Capital, Gimv, Societe Federale de Participations et dInvestissement - Federale Participatie-en Investeringsmaatschappij, and Société Régionale d'Investissement de Wallonie |
| 2019-09-04 | Nkarta | Series B | $114M | Amgen Ventures, Deerfield Management, Logos Capital, New Enterprise Associates, Novo Ventures, RA Capital Management, Samsara BioCapital, and SR One |
| 2019-07-31 | Alize Pharma III | Series A | $75M | InnoBio, Kurma Partners, OrbiMed Advisors, Partners Innovation Fund, and Pontifax |
